Scientists work at AstraZeneca's Bangalore facility in 2003
Monday April 23, 10:22 AM
Scientists work at AstraZeneca's Bangalore facility in 2003. AstraZeneca says it has agreed to buy US biotechnology company MedImmune for 15.6 billion dollars (11.5 billion euros) in total.